REGENXBIO Inc.RGNXNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank83
3Y CAGR+14.8%
5Y CAGR+2.0%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+14.8%/yr
vs -15.3%/yr prior
5Y CAGR
+2.0%/yr
Recent acceleration
Acceleration
+30.0pp
Accelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$170.44M+104.5%
2024$83.33M-7.7%
2023$90.24M-19.9%
2022$112.72M-76.0%
2021$470.35M+204.3%
2020$154.57M+338.7%
2019$35.23M-83.9%
2018$218.50M+2002.4%
2017$10.39M+126.5%
2016$4.59M-